Hifmac may be available in the countries listed below.
Ingredient matches for Hifmac
Bufexamac is reported as an ingredient of Hifmac in the following countries:
- Japan
International Drug Name Search
Hifmac may be available in the countries listed below.
Bufexamac is reported as an ingredient of Hifmac in the following countries:
International Drug Name Search
Spironolactone Altizide Teva may be available in the countries listed below.
Altizide is reported as an ingredient of Spironolactone Altizide Teva in the following countries:
Spironolactone is reported as an ingredient of Spironolactone Altizide Teva in the following countries:
International Drug Name Search
Xafenor may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Xafenor in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Chlortetracycline is reported as an ingredient of Chlortetracyclin in the following countries:
Chlortetracycline bisulfate (a derivative of Chlortetracycline) is reported as an ingredient of Chlortetracyclin in the following countries:
Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Chlortetracyclin in the following countries:
International Drug Name Search
Valsil may be available in the countries listed below.
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valsil in the following countries:
International Drug Name Search
Simavas may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simavas in the following countries:
International Drug Name Search
Treating and preventing symptoms of hay fever, other allergies, and colds. It may also be used for other conditions as determined by your doctor.
Brompheniramine 24-Hour Sustained-Release Capsules are an antihistamine. It works by blocking the action of histamine, a chemical released during allergic reactions.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Brompheniramine 24-Hour Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Brompheniramine 24-Hour Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Brompheniramine 24-Hour Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Brompheniramine 24-Hour Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Brompheniramine 24-Hour Sustained-Release Capsules.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Dizziness; drowsiness; dry mouth, throat, and nose; thickening of mucus in nose or throat.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fast or irregular heartbeat; fever; mental or mood changes; shortness of breath; sore throat; unusual bleeding or bruising; unusual tiredness or weakness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Brompheniramine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bizarre behavior; constipation; enlarged pupils; excitement; flushing; hallucinations; seizures; severe dizziness; severe drowsiness.
Store Brompheniramine 24-Hour Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Brompheniramine 24-Hour Sustained-Release Capsules out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Brompheniramine 24-Hour Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.